Buscar

Estamos realizando la búsqueda. Por favor, espere...

Malondialdehyde serum levels in a full characterized series of 430 rheumatoid arthritis patients

Abstract: Background. Oxidative stress has been involved in the pathogenesis of rheumatoid arthritis (RA). The serum malondialdehyde (MDA) level is a reliable biomarker of oxidative stress status. In the present work, we aimed to analyze how a comprehensive characterization of the disease characteristics in RA, including a lipid profile, insulin resistance, and subclinical atherosclerosis, relates to serum MDA levels. Methods. In a cross-sectional study that included 430 RA patients, serum MDA levels were evaluated. Multivariable analysis was performed to examine the relationship of MDA with disease activity scores and disease characteristics, including subclinical carotid atherosclerosis, a comprehensive lipid molecule profile, and indices of insulin resistance and beta cell function indices. Results. The erythrocyte sedimentation rate (ESR) showed a significant and positive relationship with MDA. However, this did not occur for other acute phase reactants such as C-reactive protein or interleukin-6. Although the DAS28-ESR score (Disease Activity Score in 28 joints) had a positive and significant association with MDA serum levels, other disease activity scores that do not use the erythrocyte sedimentation rate in their formula did not show a significant relationship with MDA. Other disease characteristics, such as disease duration and the existence of rheumatoid factor and antibodies against citrullinated protein, were not related to serum MDA levels. This also occurred for lipid profiles, insulin resistance indices, and subclinical carotid atherosclerosis, for which no associations with circulating MDA were found. Conclusions. The disease characteristics are not related to circulating MDA levels in patients with RA.

 Autoría: Merino de Paz N., Quevedo-Abeledo J.C., Gómez-Bernal F., de Vera-González A., Abreu-González P., Martín-González C., González-Gay M.Á., Ferraz-Amaro I.,

 Fuente: Journal of Clinical Medicine, 2024, 13, 901

 Editorial: MDPI

 Año de publicación: 2024

 Nº de páginas: 12

 Tipo de publicación: Artículo de Revista

 DOI: 10.3390/jcm13030901

 ISSN: 2077-0383

Autoría

MERINO DE PAZ, NAYRA

QUEVEDO-ABELEDO, JUAN CARLOS

GÓMEZ-BERNAL, FUENSANTA

VERA-GONZÁLEZ, ANTONIA DE

ABREU-GONZÁLEZ, PEDRO

MARTÍN-GONZÁLEZ, CANDELARIA